Qi Xiaoyu – Trademark Portfolio
Entity Type: 01
Qi Xiaoyu owns a portfolio of 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as ASHDGY, FLIKST, MHSGFA, ZAGZOG, and CHAJKTA. Of these, 10 are registered. The portfolio spans 4 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 5 (Pharmaceuticals). Headquartered in Dalian.
Centre road, Pulandian City
1-2-7-201, No.23, Section 1
Dalian 116222 , CN
Showing of trademarks Trademarks
Trademark Classifications
Qi Xiaoyu's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Carpets, rugs, mats and matting, linoleum and other materials for covering floors
Frequently Asked Questions
How many trademarks does Qi Xiaoyu have?
Qi Xiaoyu has 11 U.S. trademarks filed with the USPTO. Of these, 10 registered, 1 abandoned.
What trademark classes does Qi Xiaoyu file in?
Qi Xiaoyu files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 27 (Floor Coverings). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Qi Xiaoyu's most well-known trademarks?
Qi Xiaoyu's registered trademark portfolio includes well-known marks such as ASHDGY, FLIKST, MHSGFA, ZAGZOG, and CHAJKTA. These are among 10 currently registered trademarks in the portfolio.
What is Qi Xiaoyu's trademark registration success rate?
Qi Xiaoyu has a 91% trademark registration rate, with 10 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.